1Research progress on PNH clone screening and diagnosisLI Li-yan, FU RongSYMPOSIUM · PAROXYSMAL NOCTURNAL HEMOGLOBINURIA541-547,5532Therapeutic goal and drug choice of paroxysmal nocturnal hemoglobinuriaSHI JunSYMPOSIUM · PAROXYSMAL NOCTURNAL HEMOGLOBINURIA548-5533Efficacy evaluation of complement inhibitors and clinical follow-up of paroxysmal nocturnal hemoglobinuriaHAN BingSYMPOSIUM · PAROXYSMAL NOCTURNAL HEMOGLOBINURIA554-5584Extravascular hemolysis and breakthrough hemolysis of paroxysmal nocturnal hemoglobinuriaHE Guang-sheng, QIN Cheng-taoSYMPOSIUM · PAROXYSMAL NOCTURNAL HEMOGLOBINURIA559-5635Management of common complications and comorbidities in paroxysmal nocturnal hemoglobinuriaJIA Jin-songSYMPOSIUM · PAROXYSMAL NOCTURNAL HEMOGLOBINURIA564-569,5876Cloning evolution mechanism of paroxysmal nocturnal hemoglobinuriaZHOU Rui-qing, WANG Shun-qingSYMPOSIUM · PAROXYSMAL NOCTURNAL HEMOGLOBINURIA570-5757Expert consensus on insomnia treated by cognitive behavioral therapy combined with drug or physical therapySleep Group of Neurology Branch of Chinese Medical Doctor Association, Research Group of National Key R&D Plan(2022YFC2503900)of Ministry of Science and Technology, WANG Hong-xing, SU Chang-junGUIDELINE AND CONSENSUS576-5878Interpret of Preferred Reporting Items for Microbiotherapy Guidelines(PRIM 2024)ZHANG Zu-lun, WU Xia, CUI Bo-ta, ZHANG Fa-mingSTANDARDS AND INTERPRETATION588-5929Analysis of persistent anemia following Eculizumab treatment in paroxysmal nocturnal hemoglobinuria patients with high disease-activity statusZHANG Ting, YUAN Ying-ying, QIN Cheng-tao, MA Yong-chao, GONG Yue-min, ZHANG Ya-wen, FANG Bao-zhi, LYU Ming-en, XU Jin-ge, SHI Xiao-feng, HE Guang-sheng, SHI Jin-ningORIGINAL CONTRIBUTION593-599,60510Analysis of hematology ICU treatment of patients with hematological malignancies complicated with critical COVID-19LI Qian, XIE Yan, LIANG Pei-qi, LIU Zi-yi, WANG Dong, GAO Meng, LI Wei-yang, WANG Ying, WU De-pei, FU Jian-hongORIGINAL CONTRIBUTION600-60511Predictive value of serum intestinal fatty acid-binding protein in the risk of rebleeding in patients with hepatitis B cirrhosis and esophagogastric varicealHAN Cai-jun, WU Zheng-xie, HUANG Yuan, JIN Xing, ZHANG Xiang-lanORIGINAL CONTRIBUTION606-612 